![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Carcinoma, Ductal - 50 Studies Found
Active, not recruiting |
: Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast : Carcinoma, Ductal, Breast : 2007-05-03 :
|
Not yet recruiting |
: Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ : Ductal Carcinoma In Situ : 2016-08-30 : Procedure: Sentinel lymph node biopsy (SLNB) Intervention is defined as that the DCIS patient has underg |
Completed |
: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ : Ductal Carcinoma in Situ : 2012-06-20 : Dietary Supplement: Black cohosh Remifemin 20 mg tablet orally twice per day x 4 weeks |
Completed |
: Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) : Ductal Carcinoma In Situ : 2008-04-28 :
|
Completed |
: Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast : Ductal Carcinoma In Situ : 2007-07-03 : Drug: Herceptin (Trastuzumab) 8 mg/kg IV Over 90 Minutes |
Recruiting |
: Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL) : Collecting Duct Carcinoma (Kidney) : 2015-02-09 : Drug: Bevacizumab Patients will be treated for a maximum o |
Terminated |
: Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast : Ductal Carcinoma in Situ : 2009-03-06 : Drug: lapatinib 1500 mg lapatinib for 14-21 days Oth |
Terminated |
: A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ : Ductal Carcinoma in Situ : 2010-01-29 : Drug: Polyphenon E three 200mg capsules (600mg total dose of the study drug) with food (within one hour |
Terminated |
: Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma : Non-curative Resectable Bile Duct Carcinoma : 2009-11-16 : Drug: Temoporfin Drug treatment: Temoporfin 0.15 mg/kg bod |
Recruiting |
: Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer : Carcinoma, Ductal, Breast : 2013-05-14 :
|